Matrix Capital Management Company, LP

Holdings History for Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Symbol: ZNTL on Nasdaq
Investment type: Equity / Common Stock,$0.001 par value per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Matrix Capital Management Company, LP ownership in Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL)

02 Jan 2026 - Matrix Capital Management Company, LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL). This represents 0% ownership of the company. In their previous filing dated 15 Dec 2025, Matrix Capital Management Company, LP had reported owning 6,459,973 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Matrix Capital Management Company, LP	0%	-100%	$0	0	-6,459,973	-100%	$1.50	13D/A	30 Dec 2025	02 Jan 2026, 16:10
Matrix Capital Management Company, LP	10%		$9,689,960	6,459,973			$1.50	13D/A	15 Dec 2025	15 Dec 2025, 17:16

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-20%	$0	0	-13,959,973	-100%	$2.55	Q4 2025
30 Sep 2025	20%	0%	$21,079,559	13,959,973	0		$1.51	Q3 2025
30 Jun 2025	7.3%	0%	$16,193,569	13,959,973	0		$1.16	Q2 2025
31 Mar 2025	6.4%	0%	$22,196,357	13,959,973	0		$1.59	Q1 2025
31 Dec 2024	2%	0%	$42,298,718	13,959,973	0		$3.03	Q4 2024
30 Sep 2024	2.5%	0%	$51,372,701	13,959,973	0		$3.68	Q3 2024
30 Jun 2024	0.43%	0%	$57,096,290	13,959,973	0		$4.09	Q2 2024
31 Mar 2024	2%	0%	$220,009,174	13,959,973	0		$15.76	Q1 2024
31 Dec 2023	2.2%	0%	$211,493,591	13,959,973	0		$15.15	Q4 2023
30 Sep 2023	3.4%	0%	$280,037,058	13,959,973	0		$20.06	Q3 2023
30 Jun 2023	4.6%	+1.6%	$393,810,838	13,959,973	+4,760,000	+52%	$28.21	Q2 2023
31 Mar 2023	2.1%	0%	$158,239,536	9,199,973	0		$17.20	Q1 2023
31 Dec 2022	3.5%	0%	$185,287,456	9,199,973	0		$20.14	Q4 2022
30 Sep 2022	3.8%	0%	$199,271,000	9,199,973	0		$21.66	Q3 2022
30 Jun 2022	5.9%	+3.1%	$258,519,000	9,199,973	+4,850,694	+112%	$28.10	Q2 2022
31 Mar 2022	2.4%	0%	$200,676,000	4,349,279	0		$46.14	Q1 2022
31 Dec 2021	4.1%	0%	$365,600,000	4,349,279	0		$84.06	Q4 2021
30 Sep 2021	3.3%	+0.19%	$289,836,000	4,349,279	+248,540	+6.1%	$66.64	Q3 2021
30 Jun 2021	2.4%	+0.16%	$218,159,000	4,100,739	+279,000	+7.3%	$53.20	Q2 2021
31 Mar 2021	1.9%	0%	$165,825,000	3,821,739	0		$43.39	Q1 2021
31 Dec 2020	2.1%	0%	$198,501,000	3,821,739	0		$51.94	Q4 2020
30 Sep 2020	1.7%	0%	$124,933,000	3,821,739	0		$32.69	Q3 2020
30 Jun 2020	2.9%	+2.9%	$183,520,000	3,821,739	+3,821,739	NEW	$48.02	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.